What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Asthma
- Surgery
Her primary areas of investigation include Asthma, Anesthesia, Bronchodilator, Internal medicine and Placebo.
Anne E. Tattersfield interconnects Corticosteroid, Surgery, Physical therapy and Histamine in the investigation of issues within Asthma.
The various areas that Anne E. Tattersfield examines in her Anesthesia study include Prostaglandin E2 and Bronchodilatation.
Her research investigates the link between Bronchodilator and topics such as Budesonide that cross with problems in Salmeterol.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Allergen.
Her Placebo study integrates concerns from other disciplines, such as Inhaler and Methacholine.
Her most cited work include:
- Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group (1289 citations)
- Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. (599 citations)
- Validity and repeatability of the IUATLD (1984) bronchial symptoms questionnaire: an international comparison (423 citations)
What are the main themes of her work throughout her whole career to date?
Anne E. Tattersfield mostly deals with Asthma, Anesthesia, Internal medicine, Bronchodilator and Placebo.
Anne E. Tattersfield works in the field of Asthma, namely Budesonide.
Anne E. Tattersfield has researched Anesthesia in several fields, including Salbutamol, Crossover study and Heart rate.
Her work in Internal medicine covers topics such as Endocrinology which are related to areas like Amiloride.
Her Bronchodilator study which covers Salmeterol that intersects with Formoterol.
Her Placebo research incorporates themes from Morning, Inhaler and Randomized controlled trial.
She most often published in these fields:
- Asthma (47.20%)
- Anesthesia (33.64%)
- Internal medicine (31.31%)
What were the highlights of her more recent work (between 2003-2020)?
- Asthma (47.20%)
- Anesthesia (33.64%)
- Corticosteroid (13.08%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Asthma, Anesthesia, Corticosteroid, Surgery and Internal medicine.
Her research in Asthma intersects with topics in Placebo and Crossover study.
Her work carried out in the field of Placebo brings together such families of science as Exacerbation and Salmeterol.
In general Anesthesia, her work in Inhalation, Arterial blood and Intravenous sodium bicarbonate is often linked to Oxygen tension linking many areas of study.
Her Internal medicine study incorporates themes from Gastroenterology and Endocrinology.
Her Bronchodilator research focuses on COPD and how it connects with Salbutamol.
Between 2003 and 2020, her most popular works were:
- Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. (228 citations)
- Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. (184 citations)
- Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. (180 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Asthma
- Surgery
Anne E. Tattersfield focuses on Surgery, Asthma, Lymphangioleiomyomatosis, Corticosteroid and Internal medicine.
Her study focuses on the intersection of Surgery and fields such as Intensive care medicine with connections in the field of Fluticasone and Bone mineral.
Her studies in Asthma integrate themes in fields like COPD, Placebo and Confidence interval.
Her Corticosteroid research integrates issues from Inhaler, Pediatrics and Adrenal insufficiency.
Her Inhaler study combines topics in areas such as Exacerbation, Anesthesia and Randomized controlled trial.
Her research in the fields of Cohort study, Clinical trial and Pulmonary function testing overlaps with other disciplines such as Angiomyolipoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
